CSIMarket
 


Siga Technologies Inc  (SIGAQ)
Other Ticker:  
 
 

SIGAQ's Revenue Growth by Quarter and Year

Siga Technologies Inc's Revenue results by quarter and year




SIGAQ Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December 4.26 2.66 1.33 0.00
III Quarter September 8.11 1.75 1.47 0.00
II Quarter June 3.91 1.90 1.19 0.00
I Quarter March 471.08 1.27 0.00 0.00
FY   487.36 7.58 3.99 0.00



SIGAQ Revenue fourth quarter 2018 Y/Y Growth Comment
Siga Technologies Inc reported Revenue surge of 60.3% year on year in the fourth quarter 2018, to $ 4.26 millions, this is lower than Siga Technologies Inc's recent average Revenue surge of 2539.6%.

Looking into fourth quarter 2018 results within Major Pharmaceutical Preparations industry 227 other companies have achieved higher Revenue growth. While Siga Technologies Inc' s Revenue jump of 60.3% ranks overall at the positon no. 4084 in the fourth quarter 2018.




SIGAQ Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December 60.3 % 100 % - -
III Quarter September 363.43 % 19.05 % - -
II Quarter June 105.79 % 59.66 % - -
I Quarter March 36992.91 % - - -
FY   6329.6 % 89.97 % - -

Financial Statements
Siga Technologies Inc's fourth quarter 2018 Revenue $ 4.26 millions SIGAQ's Income Statement
Siga Technologies Inc's fourth quarter 2017 Revenue $ 2.66 millions Quarterly SIGAQ's Income Statement
New: More SIGAQ's historic Revenue Growth >>


SIGAQ Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December -47.42 % 52 % -9.52 % -
III Quarter September 107.42 % -7.89 % 23.53 % -
II Quarter June -99.17 % 49.61 % - -
I Quarter March 17609.77 % -4.51 % - -
FY (Year on Year)   6329.6 % 89.97 % - -




Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #228
Healthcare Sector #564
Overall #4084

Revenue Y/Y Growth Statistics
High Average Low
17601.51 % 2539.6 % -47.43 %
(Sep 30 2018)   (Dec 31 2019)
Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #228
Healthcare Sector #564
Overall #4084
Revenue Y/Y Growth Statistics
High Average Low
17601.51 % 2539.6 % -47.43 %
(Sep 30 2018)   (Dec 31 2019)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Siga Technologies Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
17601.51 % 2539.6 % -47.43 %
(Sep 30 2018)  


SIGAQ's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2018 Siga Technologies Inc reported fall in Revenue from the third quarter by -47.42% to $ 4.26 millions, from $ 8.11 millions achived a quarter before.

Albeit cyclical factors normally energize IV. Quarter 2018 Revenue, that plainly has not been substantial to rescue SIGAQ's IV. Quarter outcome, Ollie  Williams, market observer said and mentioned that average quarter on quarter Revenue growth is at 2539.6% for SIGAQ.

Within Major Pharmaceutical Preparations industry 227 other companies have achieved higher Revenue quarter on quarter growth. While Siga Technologies Inc's Revenue growth quarter on quarter, overall rank is 4080.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #228
Healthcare Sector #575
Overall #4080
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #228
Healthcare Sector #575
Overall #4080
Revenue Q/Q Growth Statistics
High Average Low
17601.51 % 2539.6 % -47.43 %
(Sep 30 2018)  


SIGAQ's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2018 Siga Technologies Inc disclosed fall in Revenue from the third quarter by -47.42% to $ 4.26 millions, from $ 8.11 millions declared in the previous reporting period.

Even periodic circumstance that normally fuel IV. Quarter 2018 Revenue, were not able to rescue the IV. Quarter for the Siga Technologies Inc, Ollie  Williams, market observer wrote, he sees new challenges onward for the Major Pharmaceutical Preparations's company.

Within Major Pharmaceutical Preparations industry 227 other companies have achieved higher Revenue quarter on quarter growth. While Siga Technologies Inc's Revenue growth quarter on quarter, overall rank is 4080.


Siga Technologies Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Revenue 12 Months Ending $ 487.36 $ 485.76 $ 479.39 $ 477.39 $ 7.58
Y / Y Revenue Growth (TTM) 6329.36 % 7676.59 % 7935.52 % 8981.49 % -
Year on Year Revenue Growth Overall Ranking # 416 # 3 # 3 # 3 # 2112
Seqeuential Revenue Change (TTM) 0.33 % 1.33 % 0.42 % 6197.8 % 21.35 %
Seq. Revenue Growth (TTM) Overall Ranking # 1980 # 1544 # 1261 # 3 # 202




Cumulative Revenue growth Comment
Assuming the Siga Technologies Inc's fiscal year would have ended in Dec 31 2019, Siga Technologies Inc would have reprted above average annual Revenue surge of 6329.36% year on year, of $ 487 millions.
This marks a slow-down of the companys growth trends and from the 7676.59% surge in Sep 30 2019.

In the Healthcare sector 112 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3 to 416.

Revenue TTM Q/Q Growth Statistics
High Average Low
8981.49 %
4414.47 %
-74.85 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 122
Healthcare Sector # 113
Overall # 416

Revenue TTM Y/Y Growth Statistics
High Average Low
8981.49 %
4414.47 %
-74.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 122
Sector # 287
S&P 500 # 1980
Cumulative Revenue growth Comment
Assuming the Siga Technologies Inc's fiscal year would have ended in Dec 31 2019, Siga Technologies Inc would have reprted above average annual Revenue surge of 6329.36% year on year, of $ 487 millions.
This marks a slow-down of the companys growth trends and from the 7676.59% surge in Sep 30 2019.

In the Healthcare sector 112 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3 to 416.

Revenue TTM Q/Q Growth Statistics
High Average Low
8981.49 %
4414.47 %
-74.85 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 122
Healthcare Sector # 113
Overall # 416

Revenue TTM Y/Y Growth Statistics
High Average Low
8981.49 %
4414.47 %
-74.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 122
Sector # 287
S&P 500 # 1980




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SIGAQ's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SIGAQ's Competitors
Revenue Growth for Siga Technologies Inc's Suppliers
Revenue Growth for SIGAQ's Customers

You may also want to know
SIGAQ's Annual Growth Rates SIGAQ's Profitability Ratios SIGAQ's Asset Turnover Ratio SIGAQ's Dividend Growth
SIGAQ's Roe SIGAQ's Valuation Ratios SIGAQ's Financial Strength Ratios SIGAQ's Dividend Payout Ratio
SIGAQ's Roa SIGAQ's Inventory Turnover Ratio SIGAQ's Growth Rates SIGAQ's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2019
Sangamo Therapeutics Inc 104.39%$ 104.386 millions
Edesa Biotech Inc 103.27%$ 103.270 millions
Antares Pharma Inc 101.05%$ 101.047 millions
Dynavax Technologies Corporation98.76%$ 98.759 millions
Nephros Inc 96.09%$ 96.092 millions
Clearday Inc 94.00%$ 94.000 millions
Misonix Inc 93.80%$ 93.800 millions
Portola Pharmaceuticals inc 91.19%$ 91.188 millions
Precision Optics Corporation Inc 89.25%$ 89.245 millions
Sorrento Therapeutics Inc 88.11%$ 88.108 millions
Elite Pharmaceuticals Inc 87.65%$ 87.646 millions
Theravance Biopharma inc 87.45%$ 87.450 millions
Amarin Corp Plcuk85.28%$ 85.282 millions
Miragen Therapeutics Inc 84.87%$ 84.874 millions
Sanuwave Health Inc 83.05%$ 83.050 millions
Kyto Technology And Life Science Inc 80.00%$ 80.000 millions
Tivity Health Inc 78.25%$ 78.250 millions
Aytu Biopharma Inc 76.89%$ 76.892 millions
Biodelivery Sciences International Inc 75.49%$ 75.488 millions
La Jolla Pharmaceutical Company73.28%$ 73.279 millions
Ra Pharmaceuticals Inc 72.56%$ 72.560 millions
Axim Biotechnologies Inc 71.48%$ 71.483 millions
T2 Biosystems Inc 71.26%$ 71.261 millions
Aerie Pharmaceuticals Inc 70.57%$ 70.566 millions
Amicus Therapeutics inc 69.38%$ 69.382 millions
Summit Therapeutics Inc 69.21%$ 69.212 millions
Fate Therapeutics Inc 68.69%$ 68.694 millions
Seagen Inc 66.06%$ 66.064 millions
Veru Inc 66.01%$ 66.013 millions
Lineage Cell Therapeutics Inc 63.72%$ 63.720 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com